NB
NeuBase Therapeutics
NBSE·NASDAQPittsburgh PAFounded 201820 employees
Micro CapbiotechPublicGenetic MedicineNeurology
Platform: PATrOL ASO
Market Cap
$0.01B
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (NBSE)
Loading NBSE stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Datoglumide | NBS-1184 | Phase 1 | 2 | AuroraA | GIST | ||
| NBS-1842 | NBS-1842 | NDA/BLA | 2 | FcRn | LN |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)